Medical Weight Management

Learn the pancreatitis and gallbladder warning signs associated with GLP-1 medicines, how they differ from common GI effects, and when to seek emergency care.

Understand the FDA differences between approved GLP-1 medicines and compounded semaglutide or tirzepatide, including salt forms, sourcing, shipping, and dosing risks.

Why GLP-1 weight loss can slow or stall—and how biology, routines, body composition, and clinician-guided reassessment fit together.

Why obesity and low testosterone often occur together—and why a low result does not automatically mean TRT. Evaluation, metabolic context, and repeat morning labs come first.

Why appetite and weight may rebound after stopping a GLP-1, what the STEP 1 extension found, and why long-term follow-up matters.

Why scale weight is not muscle—and how protein, resistance training, and evaluation-first care may support body composition during GLP-1 weight loss.

A practical guide to common GLP-1 side effects, when to contact your provider, and red-flag symptoms that require urgent or emergency care.

A clear comparison of semaglutide and tirzepatide for men, including GLP-1 vs dual GIP/GLP-1 action, product indications, risks, and evaluation-first care.

Educational guide to GLP-1 medications for men: how they work, FDA indications, candidates, side effects, and approved pathways.

Learn what happens during a medical weight-management consultation, including health history, goals, selective labs, lifestyle planning, and treatment discussions.